单位(元)广发创新医疗两年持有期混合C(010732)利润表 |
报告期 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
收入 |
-94,024,386 |
-82,279,566 |
-193,691,498 |
-103,341,368 |
利息收入 |
204,627 |
84,422 |
159,006 |
84,636 |
其中:存款利息收入 |
204,627 |
84,422 |
159,006 |
84,636 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益 |
-163,076,009 |
-115,577,015 |
-151,814,426 |
-104,698,759 |
其中:股票投资收益 |
-167,132,571 |
-118,468,117 |
-153,912,188 |
-106,091,608 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
2,814 |
2,814 |
16,984 |
11,202 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
4,053,749 |
2,888,288 |
2,080,778 |
1,381,646 |
公允价值变动收益 |
68,846,995 |
33,213,026 |
-42,036,078 |
1,272,754 |
汇兑收益 |
- |
- |
- |
- |
其他收入 |
- |
- |
- |
- |
费用 |
8,951,187 |
5,466,058 |
11,365,632 |
5,776,545 |
管理人报酬 |
7,098,344 |
4,367,001 |
9,097,936 |
4,629,026 |
托管费 |
1,183,057 |
727,834 |
1,516,323 |
771,504 |
销售服务费 |
470,448 |
270,442 |
553,650 |
278,080 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
199,337 |
100,781 |
197,724 |
97,935 |
利润总额 |
-102,975,573 |
-87,745,624 |
-205,057,131 |
-109,117,914 |
减:所得税费用 |
- |
- |
- |
- |
净利润 |
-102,975,573 |
-87,745,624 |
-205,057,131 |
-109,117,914 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。